ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
36 announcements with these filters
SMS Pharmaceuticals Ltd reported revenue from operations of ₹237.9 Cr (-4.1% YoY) and net profit of ₹32.7 Cr (+61.1% YoY) for Q4 FY26.
SMS Pharmaceuticals reported audited FY26 results and recommended a ₹0.40 per share final dividend. The company also approved shifting its registered office within Hyderabad.
SMS Pharmaceuticals scheduled a board meeting for May 22, 2026, to approve annual audited results and final dividend. Trading window remains closed until May 24, 2026.
SMS Pharmaceuticals Limited confirmed it does not fall under the 'Large Corporate' category as of March 31, 2026, per SEBI framework. Consequently, provisions for initial and annual disclosures regarding fund raising through debt securities are not applicable to the company.
SMS Pharmaceuticals Limited received a rectification order from the Income Tax Department for AY 2018-19. The order significantly reduces the company's tax demand from ₹7.19 Crore to ₹40.28 Lakhs. The company is reevaluating further steps and states there is no material impact on its financial or operational activities.
SMS Pharmaceuticals Ltd submitted its quarterly certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. The Registrar and Share Transfer Agent confirmed the dematerialization and cancellation of security certificates. This is a routine administrative filing with no material financial impact.